首页> 美国卫生研究院文献>CPT: Pharmacometrics Systems Pharmacology >Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinsons Disease Rating Scale
【2h】

Predicting the longitudinal changes of levodopa dose requirements in Parkinson’s disease using item response theory assessment of real‐world Unified Parkinsons Disease Rating Scale

机译:利用物品响应理论评估现实世界统一帕金森病评定规模的项目响应理论评估预测蒿岛病的纵向变化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Item response theory (IRT) has been recently adopted to successfully characterize the progression of Parkinson's disease using serial Unified Parkinson's Disease Rating Scale (UPDRS) measurements. However, it has yet to be applied in predicting the longitudinal changes of levodopa dose requirements in the real‐world setting. Here we use IRT to extract two latent variables that represent tremor and non‐tremor‐related symptoms from baseline assessments of UPDRS Part III scores. We show that relative magnitudes of the two latent variables are strong predictors of the progressive increase of levodopa equivalent dose (LED). Retrospectively collected item‐level UPDRS Part III scores and longitudinal records of prescribed medication doses of 128 patients with de novo PD extracted from the electronic medical records were used for model building. Supplementary analysis based on a subset of 36 patients with at least three serial assessments of UPDRS Part III scores suggested that the two latent variables progress at significantly different rates. A web application was developed to facilitate the use of our model in making individualized predictions of future LED and disease progression.
机译:物品响应理论(IRT)最近已被采用序列统一帕金森病评定量表(UPDRS)测量成功地表征帕金森病的进展。然而,尚未应用于预测现实世界环境中左旋多巴剂量要求的纵向变化。在这里,我们使用IRT提取两个潜在的变量,从UPDRS第III部分的基准评估中提取两个潜在的与非震颤相关症状。我们表明,两个潜在变量的相对幅度是Levodopa等效剂量(LED)逐渐增加的强预测因子。回顾性收集的物品级UPDRS部分III分数和规定的药物药物剂量的128名患者中的128例从电子医疗记录中提取的患者的纵向记录用于模型建筑。基于36名患者的补充分析,患有至少三个UPDRS第III部分分数的患者的分数表明,两个潜在的变量以显着不同的速率进行了进展。开发了一个网络申请,以促进我们模型在使未来LED和疾病进展的个性化预测中的使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号